|The DERL2 derl2 (Catalog #MBS625049) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The DERL2, CT (Derlin-2, Der1-like Protein 2, Degradation In Endoplasmic Reticulum Protein 2, DERtrin-2, F-LAN-1, F-LANa, SBBI53, CGI-101, FLANA, DER2) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s DERL2 can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA), Western Blot (WB).
Suitable for use in ELISA and Western Blot.
Dilution: ELISA: 1:1,000
Western Blot: 1:100-1:500. Researchers should empirically determine the suitability of the DERL2 derl2 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The DERL2 derl2 product has the following accession number(s) (GI #31455614) (NCBI Accession #NP_057125.2) (Uniprot Accession #Q9GZP9). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
DERL2, CT (Derlin-2, Der1-like Protein 2, Degradation In Endoplasmic Reticulum Protein 2, DERtrin-2, F-LAN-1, F-LANa, SBBI53, CGI-101, FLANA, DER2)
Proteins that are unfolded or misfolded in the endoplasmic reticulum (ER) must be refolded or degraded to maintain the homeostasis of the ER. DERL2 is involved in the degradation of misfolded glycoproteins in the ER.
Immunogen: Synthetic peptide selected from the C-terminal region of human DERL2 (KLH). In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing DERL2 are readily searchable from our website. Different antibodies against the same target such as DERL2 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. The following patways have been known to be associated with this gene. Blood, Embryonic Tissue, Kidney, Liver tissues are correlated with this protein. Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, Cell Transformation, Neoplastic, Fetal Death, Liver Diseases, Liver Neoplasms, Neoplasms, Neoplasms, Experimental are some of the diseases may be linked to DERL2, CT (Derlin-2, Der1-like Protein 2, Degradation In Endoplasmic Reticulum Protein 2, DERtrin-2, F-LAN-1, F-LANa, SBBI53, CGI-101, FLANA, DER2).